Foreign

Fourth iteration of COVID-19 treatment trial underway in United States

Published

on

The United States National Institute of Allergy and Infectious Diseases (NIAID) announced on Wednesday that the fourth iteration of the Adaptive COVID-19 Treatment Trial (ACTT-4) has begun to enroll hospitalized COVID-19 adults who require supplemental oxygen.

The NIAID-sponsored trial will enroll up to 1,500 patients at approximately 100 sites in the United States and other countries.

Participants will be assigned at random to one of two treatment arms of equal size. One group will receive both dexamethasone, a corticosteroid available as a generic drug, and remdesivir, a broad-spectrum antiviral discovered and developed by American drugmaker Gilead Sciences.

The second group will receive remdesivir and baricitinib, a modulator of inflammation that is approved by the United States Food and Drug Administration to treat certain adult patients with moderate to severe rheumatoid arthritis.

FDA granted Emergency Use Authorization on Nov. 19 for baricitinib in combination with remdesivir to treat suspected or laboratory confirmed COVID-19 in hospitalized patients aged 2 years and older who require supplemental oxygen, invasive mechanical ventilation, or extracorporeal membrane oxygenation.

The trial is blinded for the dexamethasone and baricitinib components, meaning investigators and participants will not know who is receiving dexamethasone and who is receiving baricitinib.

The trial will evaluate the difference in the proportion of participants surviving without requiring invasive mechanical ventilation between the two treatment arms, according to the NIAID.

A key secondary goal is to compare overall clinical status at day 15 in each group by comparing differences in the distribution of the eight-point ordinal scale in each group, said the agency.

(XINHUA)

NNN

NNN: :is a Nigerian online news portal that publishes breaking news in Nigeria, and across the world. Our journalists are honest, fair, accurate, thorough and courageous in gathering, reporting and interpreting news in the best interest of the public, because truth is the cornerstone of journalism and they strive diligently to ascertain the truth in every news report. Contact: editor[at]nnn.com.ng

Latest News

Coronavirus – Nigeria: COVID-19 update (25 January 2021) Coronavirus – Zambia: COVID-19 update (25 January 2021) Coronavirus – Kenya: COVID-19 update (25 January 2021) 34th AU Summit strives to leverage and valorise African Arts, Culture and Heritage Signing of memorandum of understanding (MoU) Between Development of the Private Sector (ICD) and SQB Securities, Uzbekistan Africa's top business leaders to participate in awards to celebrate India's republic day to independence day Register to hear Musa Kalenga on leapfrogging tech in Africa at #BizTrends2021 Unstoppable Paule Ella Guei honoured with Sports+ Award Her Excellency Fatoumata CM Jallow Tambajang and her commitment to serve the people of Africa Coronavirus – Rwanda: COVID-19 update (25 January 2021) Coronavirus – Gambia: COVID-19 update (25 January 2021) Kenya adopts Trusted Travel digital tool for COVID-19 test result verification Coronavirus: African Union Member States reporting COVID-19 cases as of 25 January 2021, 9 am EAT Coronavirus – Uganda: COVID-19 update (24 January 2021) Beyond COVID: Prioritizing NTD agenda and sustainable local financing International Islamic Trade Finance Corporation (ITFC) announces the launching of the 2nd phase of the Aid for Trade Initiative for Arab States (AfTIAS 2.0) in June 2021 to Mitigate the Effects of COVID-19 on Trade in the Arab Region Coronavirus: African Union Member States reporting COVID-19 cases as of 24 January 2021, 6 pm EAT New Report on African media shows western sources dominate how the Africa story is told Coronavirus – Malawi: COVID-19 update (24 January 2021) Coronavirus – Kenya: COVID-19 update (24 January 2021) Coronavirus – Zambia: COVID-19 update (24 January 2021) Sudan kicks off second response campaign against polio outbreak Rugby Africa announces competition program and calendar for 2021 Coronavirus – Eswatini: COVID-19 update (24 January 2021) Situation in Central African Republic II: Mahamat Said Abdel Kani surrendered to the ICC for crimes against humanity and war crimes Coronavirus – Rwanda: COVID-19 update (24 January 2021) Coronavirus – South Africa: COVID-19 update (24 January 2021) Community health workers must be better supported in 2021, the Year of the Healthcare Worker Coronavirus – Malawi: COVID-19 update (23 January 2021) Coronavirus – Rwanda: COVID-19 update (23 January 2021) Coronavirus – Uganda: COVID-19 update (23 January 2021) Coronavirus – Ethiopia: COVID-19 update (23 January 2021) Vision of H.E. Moussa Faki Mahamat for the term of office 2021-2024 Coronavirus – Zimbabwe: COVID-19 update (23 January 2021) Coronavirus – Nigeria: COVID-19 update (23 January 2021) Coronavirus – Zambia: COVID-19 update (23 January 2021) Coronavirus – Kenya: COVID-19 update (23 January 2021) Coronavirus – Gambia: The variant strain of the SARS-CoV-2 virus first detected in the United Kingdom has been identified during sequencing in positive specimens at the National Public Health Laboratory Services Sierra Leone’s President Julius Maada Bio launches the Sierra Leone Health Village, turns Sod for the Construction of Ultra-Modern General Hospital at Kerry Town Devastation feared as Eloise approaches Mozambique Coronavirus – Ethiopia: COVID-19 update (22 January 2021) Coronavirus – Rwanda: COVID-19 update (22 January 2021) Coronavirus – Eswatini: COVID-19 update (22 January 2021) Coronavirus – Zimbabwe: COVID-19 update (22 January 2021) Coronavirus – Malawi: COVID-19 update (22 January 2021) Football: Ahmad’s old guards maintain West’s stranglehold on Confederation of African Football (CAF) Coronavirus – Nigeria: COVID-19 update (22 January 2021) Coronavirus – Zambia: COVID-19 update (22 January 2021) Coronavirus – Kenya: COVID-19 update (22 January 2021) Frightened Residents brace as Cyclone Eloise approaches Mozambique